Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone

NCT01536691 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

338

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Malignancy

Interventions

DRUG: ramosetron
DRUG: ondansetron

Sponsor

Hallym University Medical Center

Collaborators

[object Object]
[object Object]